Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. H.J. (Henkjan) Verkade

Publications

Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials

Old habits die hard: The age at Kasai portoenterostomy in European infants with biliary atresia

Old habits die hard: The age at Kasai portoenterostomy in European infants with biliary atresia

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review

Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper

Transmission and dynamics of mother-infant gut viruses during pregnancy and early life

Treatment strategies for hepatic artery complications after pediatric liver transplantation: A systematic review

Albuminuria and markers for cardiovascular risk in 12-year-olds from the general Dutch population: a cross-sectional study

Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database

Read more

Press/media

Toename acute hepatitis bij jonge kinderen mogelijk door overdraagbare oorzaak

Al drie levertransplantaties na mysterieuze kinderhepatitis: dit weten we inmiddels

RIVM en WHO waarschuwen voor leverziekte onder kinderen

Bijzonder goede prognose voor kinderen na levertransplantatie

Prognose voor kinderen die levertransplantatie ondergaan erg goed

Onderzoek UMCG: Getransplanteerde lever bij kind blijft vaak decennialang werken

Levertransplantaties voor kinderen opvallend succesvol

Interview national radio (NPO1): "Met het oog op morgen"

Read more